Nuzenio

Solvonis Therapeutics

Solvonis Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 3 publisher sources 100/100 entity strength

Latest news

US drug agency to fund further testing of Solvonis addiction candidate - UPDATE - Proactive financial newsProactive financial news · Thu, 06 Aug 2026 10:11:26 GMTSolvonis Therapeutics' SVN-015 Progresses to Advanced NIDA-Funded Preclinical Trials Following Positive Cardiac Ion-Channel Screening - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 06:00:09 GMTSolvonis’ SVN-015 Cleared for Further NIDA Studies in Stimulant Use Disorder - tipranks.comtipranks.com · Wed, 05 Aug 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 10:11:26 GMTUS drug agency to fund further testing of Solvonis addiction candidate - UPDATE - Proactive financial news
Thu, 06 Aug 2026 06:00:09 GMTSolvonis Therapeutics' SVN-015 Progresses to Advanced NIDA-Funded Preclinical Trials Following Positive Cardiac Ion-Channel Screening - Kalkine Media
Wed, 05 Aug 2026 07:00:00 GMTSolvonis’ SVN-015 Cleared for Further NIDA Studies in Stimulant Use Disorder - tipranks.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Solvonis Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.